“As GDP inspectors, we often saw companies spending significant amounts of time, effort & resource on investigating deviations where temperature excursions occurred when using a non-wireless monitoring device i.e., manual monitoring devices.

Constant tracking provides greater assurance temperature excursions can be identified and assessed immediately as real time data is continuously collected. This is where JTF makes all the difference by focusing on reducing risk to the medicinal product and ultimately protecting the patient.

Although it’s not mandatory in GDP to use a wireless temperature monitoring device, having the ability to pro-actively deal with a potential excursion helps reduce  risk and allows you to maintain your regulatory compliance.